¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"potentially toxic compound"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cryoprotective compound
    µ¿°á¹æÁöÁ¦
  • cyclic compound
    °í¸®È­ÇÕ¹°
  • chain compound
    »ç½½È­ÇÕ¹°
  • exothermic compound
    ¹ß¿­È­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°
  • high energy compound
    °í¿¡³ÊÁöÈ­ÇÕ¹°
  • high energy phosphate compound
    °í¿¡³ÊÁöÀλ꿰ȭÇÕ¹°
  • impression compound
    Àλó¿ëÄÞÆÄ¿îµå
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°
  • moulding compound impression
    ¿¬¼ºÀçÀλó
  • nonpolar compound
    ºñ±Ø¼ºÈ­ÇÕ¹°, ¹«±Ø¼ºÈ­ÇÕ¹°
  • open-chain compound
    ¿­¸°»ç½½È­ÇÕ¹°
  • organic compound
    À¯±âÈ­ÇÕ¹°
  • polyfunctional compound
    ´Ù±â´ÉÈ­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • toxic peripheral neuropathy
    µ¶¼º¸»ÃʽŰ溴Áõ
  • toxic psychosis
    µ¶¼ºÁ¤½Åº´
  • toxic reaction
    µ¶¹ÝÀÀ, Áßµ¶¹ÝÀÀ
  • toxic retinopathy
    Áßµ¶¸Á¸·º´Áõ
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic shock
    µ¶¼º¼îÅ©
  • toxic stomatitis
    µ¶¼ºÀԾȿ°, µ¶¼º±¸³»¿°
  • toxic substance
    µ¶¼º¹°Áú
  • toxic shock syndrome
    µ¶¼ÒÃæ°ÝÁõÈıº
  • toxic
    µ¶¼º-, Áßµ¶-
  • toxic tolerance
    µ¶¹°³»¼º
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic chemical use
    µ¶¼ºÈ­Çй°ÁúÀÌ¿ë
  • toxic conjunctivitis
    Áßµ¶°á¸·¿°
  • toxic convulsion
    Áßµ¶¼º°æ·Ã(¡­ÌâÕý)
  • toxic convulsion
    Áßµ¶¼º°æ·Ã(¡­ÌâÕý).
  • toxic deafness
    Áßµ¶¼º³­Ã»
  • toxic delirium
    µ¶¼º¼¶¸Á(~àëØÍ).
  • toxic dementia
    Áßµ¶¼ºÄ¡¸Å(¡­öÂ?)
  • toxic diarrhea
    Áßµ¶¼º¼³»ç
  • toxic dose
    Áßµ¶(¿ë)·®(ñéÔ¸(éÄ)åÖ).
  • toxic dose
    µ¶¼º¿ë·®
  • toxic dyspepsia
    Áßµ¶¼º¼ÒÈ­ºÒ·®(ñéÔ¸àõá¼ûùÝÕåÐ)
  • toxic eczema
    Áßµ¶¼º½ÀÁø(¡­ã¥òÖ)
  • toxic edema
    Áßµ¶¼ººÎÁ¾
  • toxic effect
    Áßµ¶È¿°ú(¡­üùÍý).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CCF cancer coagulation factor; cardiolipin complement fixation; carotid-cavernous fistula; centrifuged c...
CMAP compound muscle (or motor) action potential
cmpd compound, compounded
CNAP career nurse assistants' programs; compound nerve action potential
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OPIDN organophosphorous compound-induced delayed neurotoxicity
ATSDR Agency for Toxic Substances and Disease Registry
ODTS Organic Dust Toxic Syndrome
STSS Streptococcal Toxic Shock Syndrome
TEN Toxic epidermal necrolisis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrated compound
    ¼öÈ­ È­ÇÕ¹°
  • impression compound
    Àλó¿ë ÄÞÆÄ¿îµå
    Àλó¿ë°ú Æ®·¹ÀÌ¿ëÀÌ ÀÖ°í, õ¿¬ ¼öÁö, ÇÕ¼º ¼öÁö µîÀ¸·Î µÇ¾î ¿­ °¡¼Ò¼ºÀ» °®´Â ÀλóÀç.
  • inorganic compound
    ¹«±â È­ÇÕ¹°
    ź¼Ò¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â È­ÇÕ¹°.
  • intermetallic compound
    ±Ý¼Ó°£ È­ÇÕ¹°
    ¼ººÐ ¿ø¼Ò°¡ °£´ÜÇÑ Á¤¼öºñ·Î °áÇÕÇϰí ÀÖ´Â ÇÕ±Ý.
  • modeling compound impression
    ¿¬¼ºÀç Àλó
  • molecular compound
    ºÐÀÚ È­ÇÕ¹°
  • moulding compound impression
    ¿¬¼ºÀç Àλó
  • open chain compound
    ¿­¸° »ç½½ È­ÇÕ¹°
  • organometallic compound
    À¯±â ±Ý¼Ó È­ÇÕ¹°
    À¯±â ±â¿Í °áÇÕµÈ ±Ý¼ÓÀ¸·Î ÀÌ·ç¾îÁø È­ÇÕ¹°.
  • paraffin compound
    ÆÄ¶óÇÉÁ· È­ÇÕ¹°
  • phenolic compound
    ¼®Åº»ê ÇÕÁ¦
  • racemic compound
    ¶ó¼¼¹Ì È­ÇÕ¹°
  • SH compound
    SH È­ÇÕ¹°
    SH±â¸¦ °¡Áö´Â °Í, ½Ã½ºÅ×ÀÎ, ÆÇÅäÅ×ÀÎ µîÀÌ ÀÖ´Ù.
  • unsaturated compound
    ºÒÆ÷È­ È­ÇÕ¹°, ºÒÆ÷È­¹°
    ºÐÀÚ ¾È¿¡ ź¼Ò ¿øÀÚ »çÀÌÀÇ ÀÌÁß °áÇÕ ¶Ç´Â »ïÁß °áÇÕÀ» Æ÷ÇÔÇÏ´Â À¯±â È­ÇÕ¹°.
  • vitamin compound
    ºñŸ¹Î º¹ÇÕÁ¦
    ºñŸ¹ÎÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿µ¾çÁ¦·Î¼­ ºñŸ¹Î °áÇÌÁõÀÇ Ä¡·á¿Í ¿¹¹æ¿¡ »ç¿ëµÇ´Â ÀǾàǰ. ÇöÀç ºñŸ¹Î B2¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ ºñŸ¹ÎµéÀº ÇÕ¼ºÇÒ ¼ö ÀÖ°í È­Çлê¾÷¿¡ ÀÇÇØ ´Ù·®À¸·Î Á¦Á¶°¡ °¡´ÉÇϹǷΠ´ëºÎºÐÀÇ ºñŸ¹ÎÁ¦´Â ÇÕ¼ºÇ°À¸·Î ¸¸µé¾îÁø´Ù. ´ÜÀÏ Á¦Á¦ Áß¿¡ ÇÑ Á¾·ùÀÇ ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç ´ÜÀÏ ºñŸ¹ÎÁ¦, Áö¿ë¼º ÈæÀº ¼ö¿ë¼º ºñŸ¹Î ¸î Á¾·ù¸¸À» º¹ÇÕ½ÃÄÑ ¸¸µç º¹ÇÕ ºñŸ¹ÎÁ¦, °ÅÀÇ ¸ðµç ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç Á¾ÇÕ ºñŸ¹ÎÁ¦°¡ ÀÖ¾î ¿ëµµ¿¡ µû¶ó »ç¿ëµÈ´Ù. ºñŸ¹ÎÁ¦´Â Áúº´, ¾Ë·¹¸£±â, ½Ä»çÀÇ Á¦ÇÑ µî ¾î¶² ÀÌÀ¯¿¡¼­ ÀûÀýÇÑ ½Ä»ç¸¦ ÇÏÁö ¸øÇÏ´Â »ç¶÷¿¡°Ô´Â ¸Å¿ì À¯¿ëÇϳª Á¤±Ô½Ä»ç¸¦ ÇÏ´Â °Ç°­ÇÑ »ç¶÷ÀÌ ºñŸ¹ÎÀ» ´õ º¸Ãæ¼·ÃëÇϱâ À§ÇÏ¿© »ç¿ëÇÏ´Â °ÍÀº ³¶ºñÀ̰ųª ÇØ°¡ µÇ´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î »ï°¡¾ß ÇÑ´Ù. 5°¡Áö ±âÃʽÄǰ±º¿¡ ±âº»À» µÐ ±ÕÇü½Ä»ç´Â ¸öÀÌ ÇÊ¿ä·Î ÇÏ´Â ¸ðµç ºñŸ¹ÎÀ» °ø±ÞÇϱ⿡ ÃæºÐÇϸç, Çʿ䷮ ÀÌ»óÀÇ ºñŸ¹ÎÀÌ °Ç°­¿¡ ÇØ·Ó±â ¶§¹®ÀÌ´Ù. Á¤±Ô½Ä»ç¸¦ ÅëÇÑ ºñŸ¹ÎÀÇ ¼·Ãë´Â °áÄÚ °úÀ× µ¶¼º¼öÁرîÁö °¡Áö ¾ÊÁö¸¸, ³óÃàµÈ ºñŸ¹ÎÁ¦¸¦ °è¼Ó ¸ÔÀ¸¸é °úÀ× µ¶¼º ¼öÁرîÁö À̸£°Ô µÈ´Ù. ½Ä»ç¸¦ ÅëÇÏ¿© °Ç°­À¯Áö¿Í Áúº´¿¹¹æ¿¡ ÇÊ¿äÇÑ ¸ðµç ºñŸ¹ÎÀ» ¼·ÃëÇØ¾ß ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
toxic shock See toxic shock syndrome.
(12 Dec 1998)
toxic shock syndrome <syndrome> A blood-borne bacterial infection caused by the genus Staphylococcus. Usually effects menstruating females under the age of thirty and was associated in the past with the use of a particular type of tampon (no longer used).
Common symptoms include: fever, chills, vomiting, sore throat, headache and decreased urine output. Progression of disease can result in lowering of blood pressure (shock) and renal failure.
Treatment includes hospitalisation and intravenous antibiotics emergently.
(27 Sep 1997)
toxic substances A chemical or mixture of chemicals that presents a high risk of injury to human health or to the environment.
(05 Dec 1998)
toxic tetanus Tonic spasms caused by strychnine or other tetanic.
Synonym: toxic tetanus.
(05 Mar 2000)
toxic unit A unit formerly synonymous with minimal lethal dose but which, because of the instability of toxins, is now measured in terms of the quantity of standard antitoxin with which the toxin combines.
See: L doses, minimal lethal dose.
Synonym: toxin unit.
(05 Mar 2000)
epidermal necrolysis, toxic An exfoliative disease of skin seen primarily in adults and characterised by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure.
(12 Dec 1998)
acetone compound <biochemistry> Any of the three compounds created by acetyl coenzyme A (acetoacetate, hydroxybutyrate, and acetone) which are water-soluble cellular fuels normally exported by the liver.
They can build up in the blood and body tissues because of starvation, untreated diabetes mellitus, or other disorders that interfere with carbohydrate metabolism. The body rids itself of ketones mainly through urine, but it rids itself of acetone through the lungs, which gives the breath a characteristic fruity odour. If ketones build up in the body long enough, they cause serious illness and coma (see ketoacidosis.)
(09 Oct 1997)
acyclic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
addition compound Strictly, a complex of two or more complete molecules in which each preserves its fundamental structure and no covalent bonds are made or broken (e.g., hydrates of salts, adducts), loosely, association of acids with basic organic compound's (e.g., amines with HCl), more loosely, addition of two molecules without loss of any atom, but forming new covalent bonds (e.g., CH2==CH2 + Br2 &rarr; BrCH2-CH2Br).
(05 Mar 2000)
aliphatic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
APC compound An analgesic tablet drug combination containing aspirin, phenacetin and caffeine. Very widely used in the 1940's through 1960's; original constituents of popular over-the-counter pain remedies. Use currently much diminished due to concerns about potential renal injury due to the phenacetin.
(05 Mar 2000)
aromatic compound Any compound in which the constituent atoms, or any part of them, form a ring. Used mainly in organic chemistry where: 1) numerous compound's contain rings of carbon atoms (carbocyclic compound's) or carbon atoms plus one or more atoms of other types (heterocyclic compound's), usually nitrogen, oxygen, or sulfur; 2) where the atoms in the ring are all of the same element (homocyclic or isocyclic compound); 3) where the ring is saturated or contains nonconjugated double bonds (alicyclic compound), the compound is similar in properties to the corresponding acyclic compound (e.g., cyclohexane resembles hexane); 4) where the ring contains conjugated double bonds in a closed loop in which there are 4n + 2 (where n is an integer) delocalised &pi; electrons (Huckel's rule) (aromatic compound; e.g., benzene, pyridine), it is more stable than the corresponding saturated ring and exhibits unusual chemical properties characteristic of itself and not of other types of rings or of acyclic compound's. These aromatic compounds have the ability to sustain an induced ring current.
Synonym: closed chain compound, ring compound.
(05 Mar 2000)
binary compound <chemistry> This refers to any compound that is composed of only two elements.
(09 Oct 1997)
calcium compound Inorganic compounds that contain calcium as an integral part of the molecule.
(12 Dec 1998)
carbamino compound Any carbamic acid derivative formed by the combination of carbon dioxide with a free amino group to form an N-carboxy group, -NH-COOH, as in haemoglobin forming carbaminohemoglobin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á